Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP232945.RAKBJ8Qw6JVPFRFQAwZRv7erK3kF_jxHZyewU6NiRkfBg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP232945.RAKBJ8Qw6JVPFRFQAwZRv7erK3kF_jxHZyewU6NiRkfBg130_assertion type Assertion NP232945.RAKBJ8Qw6JVPFRFQAwZRv7erK3kF_jxHZyewU6NiRkfBg130_head.
- NP232945.RAKBJ8Qw6JVPFRFQAwZRv7erK3kF_jxHZyewU6NiRkfBg130_assertion description "[EGFR overexpression was found in 87.5% (35/40) of the laryngeal primary tumors and 82.5% (33/40) of the corresponding lymph node metastases/was a good agreement between the primary tumors and the paired metastases regarding EGFR expression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP232945.RAKBJ8Qw6JVPFRFQAwZRv7erK3kF_jxHZyewU6NiRkfBg130_provenance.
- NP232945.RAKBJ8Qw6JVPFRFQAwZRv7erK3kF_jxHZyewU6NiRkfBg130_assertion evidence source_evidence_literature NP232945.RAKBJ8Qw6JVPFRFQAwZRv7erK3kF_jxHZyewU6NiRkfBg130_provenance.
- NP232945.RAKBJ8Qw6JVPFRFQAwZRv7erK3kF_jxHZyewU6NiRkfBg130_assertion SIO_000772 18172732 NP232945.RAKBJ8Qw6JVPFRFQAwZRv7erK3kF_jxHZyewU6NiRkfBg130_provenance.
- NP232945.RAKBJ8Qw6JVPFRFQAwZRv7erK3kF_jxHZyewU6NiRkfBg130_assertion wasDerivedFrom lhgdn-20090331 NP232945.RAKBJ8Qw6JVPFRFQAwZRv7erK3kF_jxHZyewU6NiRkfBg130_provenance.
- NP232945.RAKBJ8Qw6JVPFRFQAwZRv7erK3kF_jxHZyewU6NiRkfBg130_assertion wasGeneratedBy ECO_0000203 NP232945.RAKBJ8Qw6JVPFRFQAwZRv7erK3kF_jxHZyewU6NiRkfBg130_provenance.